Tornier NV (NASDAQ:TRNX)
| 16.81 Data as of Jun 19 |  -0.21 / -1.23%Today’s Change | 14.53 Today|||52-Week Range 23.54 | +0.12% Year-to-Date |
Latest TRNX News | Press Releases
No recent news for Tornier NV.
Today’s Trading
| Previous close | 17.02 |
| Today’s open | 17.00 |
| Day’s range | -- - -- |
| Volume | 151,865 |
| Average volume (3 months) | 160,238 |
| Market cap | $790.1M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +32.50% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +22.50% |
| Revenue growth (last year) | +6.25% |
| P/E ratio | -- |
| Price/Sales | 2.35 |
| Price/Book | 1.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EXASExact Sciences Corp | +0.07 | +0.55% |
| LMNXLuminex Corp | -0.39 | -1.88% |
| ABMDAbiomed Inc | +0.07 | +0.32% |
| OMCLOmnicell Inc | -0.06 | -0.31% |
Data as of 3:59pm ET, 06/19/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $277.5M |
| Annual profit (last year) | -$21.7M |
| Net profit margin | -7.84% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President & Chief Executive Officer David H. Mowry |
Chief Financial Officer Shawn T. McCormick, MBA, CPA |
Corporate headquarters Amsterdam, Noord-holland |
Forecasts
